These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17171578)

  • 1. The role of N286 and D320 in the reaction mechanism of human dihydrolipoamide dehydrogenase (E3) center domain.
    Wang YC; Wang ST; Li C; Liu WH; Chen PR; Chen LY; Liu TC
    J Biomed Sci; 2007 Mar; 14(2):203-10. PubMed ID: 17171578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of amino acids T148 and R281 in human dihydrolipoamide dehydrogenase.
    Wang YC; Wang ST; Li C; Chen LY; Liu WH; Chen PR; Chou MC; Liu TC
    J Biomed Sci; 2008 Jan; 15(1):37-46. PubMed ID: 17960497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Site-directed mutagenesis of human dihydrolipoamide dehydrogenase: role of lysine-54 and glutamate-192 in stabilizing the thiolate-FAD intermediate.
    Liu TC; Hong YS; Korotchkina LG; Vettakkorumakankav NN; Patel MS
    Protein Expr Purif; 1999 Jun; 16(1):27-39. PubMed ID: 10336857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel mutation in the dihydrolipoamide dehydrogenase E3 subunit gene (DLD) resulting in an atypical form of alpha-ketoglutarate dehydrogenase deficiency.
    Odièvre MH; Chretien D; Munnich A; Robinson BH; Dumoulin R; Masmoudi S; Kadhom N; Rötig A; Rustin P; Bonnefont JP
    Hum Mutat; 2005 Mar; 25(3):323-4. PubMed ID: 15712224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of human dihydrolipoamide dehydrogenase: NAD+/NADH binding and the structural basis of disease-causing mutations.
    Brautigam CA; Chuang JL; Tomchick DR; Machius M; Chuang DT
    J Mol Biol; 2005 Jul; 350(3):543-52. PubMed ID: 15946682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural model for human dihydrolipoamide dehydrogenase.
    Jentoft JE; Shoham M; Hurst D; Patel MS
    Proteins; 1992 Sep; 14(1):88-101. PubMed ID: 1409563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of two site-specifically mutated human dihydrolipoamide dehydrogenases (His-452----Gln and Glu-457----Gln).
    Kim H; Patel MS
    J Biol Chem; 1992 Mar; 267(8):5128-32. PubMed ID: 1347528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and characterization of a functional canine variant of cytochrome b5 reductase.
    Roma GW; Crowley LJ; Barber MJ
    Arch Biochem Biophys; 2006 Aug; 452(1):69-82. PubMed ID: 16814740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The X-ray structure of N-methyltryptophan oxidase reveals the structural determinants of substrate specificity.
    Ilari A; Bonamore A; Franceschini S; Fiorillo A; Boffi A; Colotti G
    Proteins; 2008 Jun; 71(4):2065-75. PubMed ID: 18186483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural insight into interactions between dihydrolipoamide dehydrogenase (E3) and E3 binding protein of human pyruvate dehydrogenase complex.
    Brautigam CA; Wynn RM; Chuang JL; Machius M; Tomchick DR; Chuang DT
    Structure; 2006 Mar; 14(3):611-21. PubMed ID: 16442803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human UDP-glucose dehydrogenase reveals critical catalytic roles for lysine 220 and aspartate 280.
    Easley KE; Sommer BJ; Boanca G; Barycki JJ; Simpson MA
    Biochemistry; 2007 Jan; 46(2):369-78. PubMed ID: 17209547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of human dihydrolipoamide dehydrogenase is largely reduced by mutation at isoleucine-51 to alanine.
    Kim H
    J Biochem Mol Biol; 2006 Mar; 39(2):223-7. PubMed ID: 16584639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel inhibitor for prolyl tripeptidyl aminopeptidase from Porphyromonas gingivalis and details of substrate-recognition mechanism.
    Xu Y; Nakajima Y; Ito K; Zheng H; Oyama H; Heiser U; Hoffmann T; Gärtner UT; Demuth HU; Yoshimoto T
    J Mol Biol; 2008 Jan; 375(3):708-19. PubMed ID: 18042490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site directed mutagenesis studies of FAD-dependent glucose dehydrogenase catalytic subunit of Burkholderia cepacia.
    Yamaoka H; Yamashita Y; Ferri S; Sode K
    Biotechnol Lett; 2008 Nov; 30(11):1967-72. PubMed ID: 18581061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How dihydrolipoamide dehydrogenase-binding protein binds dihydrolipoamide dehydrogenase in the human pyruvate dehydrogenase complex.
    Ciszak EM; Makal A; Hong YS; Vettaikkorumakankauv AK; Korotchkina LG; Patel MS
    J Biol Chem; 2006 Jan; 281(1):648-55. PubMed ID: 16263718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Asparagine-473 residue is important to the efficient function of human dihydrolipoamide dehydrogenase.
    Kim H
    J Biochem Mol Biol; 2005 Mar; 38(2):248-52. PubMed ID: 15826505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catalytic mechanism of inulinase from Arthrobacter sp. S37.
    Kim KY; Nascimento AS; Golubev AM; Polikarpov I; Kim CS; Kang SI; Kim SI
    Biochem Biophys Res Commun; 2008 Jul; 371(4):600-5. PubMed ID: 18395004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of human dihydrolipoamide dehydrogenase is reduced by mutation at threonine-44 of FAD-binding region to valine.
    Kim H
    J Biochem Mol Biol; 2002 Jul; 35(4):437-41. PubMed ID: 12297006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic properties of lipoamide dehydrogenase from Mycobacterium smegmatis.
    Marcinkeviciene J; Blanchard JS
    Arch Biochem Biophys; 1997 Apr; 340(2):168-76. PubMed ID: 9143318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A lipoamide dehydrogenase from Neisseria meningitidis has a lipoyl domain.
    Bringas R; Fernandez J
    Proteins; 1995 Apr; 21(4):303-6. PubMed ID: 7567952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.